P3 Health Partners Stock Analysis

PIII Stock Analysis Notes

About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. P3 Health Partners recorded a loss per share of 57.16. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 14th of April 2025. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. P3 Health operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 523 people. To find out more about P3 Health Partners contact FACEP FACP at 702 910 3950 or learn more at https://p3hp.org.

P3 Health Partners Investment Alerts

PIII Largest EPS Surprises

View All Earnings Estimates

P3 Health Environmental, Social, and Governance (ESG) Scores

PIII Stock Institutional Investors

Note, although P3 Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PIII Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 416.45 M.

PIII Profitablity

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.

Management Efficiency

P3 Health Partners has return on total asset (ROA) of (0.2085) % which means that it has lost $0.2085 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.026) %, meaning that it created substantial loss on money invested by shareholders. P3 Health's management efficiency ratios could be used to measure how well P3 Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.78. The current Return On Capital Employed is estimated to decrease to -1.06. As of now, P3 Health's Other Current Assets are increasing as compared to previous years. The P3 Health's current Intangible Assets is estimated to increase to about 565.6 M, while Net Tangible Assets are forecasted to increase to (1.6 B).

Technical Drivers

As of the 1st of February, P3 Health owns the market risk adjusted performance of (3.22), and Information Ratio of (0.44). In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of P3 Health Partners, as well as the relationship between them.

P3 Health Partners Price Movement Analysis

P3 Health Partners Insider Trading Activities

P3 Health Outstanding Bonds

P3 Health Predictive Daily Indicators

P3 Health Forecast Models

P3 Health's time-series forecasting models are one of many P3 Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary P3 Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

P3 Health Bond Ratings

P3 Health Partners financial ratings play a critical role in determining how much P3 Health have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for P3 Health's borrowing costs.

P3 Health Partners Debt to Cash Allocation

P3 Health Partners currently holds 166.16 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity.

P3 Health Common Stock Shares Outstanding Over Time

P3 Health Assets Financed by Debt

The debt-to-assets ratio shows the degree to which P3 Health uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

P3 Health Debt Ratio

24.0

It feels like most of the P3 Health's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the P3 Health's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of P3 Health, which in turn will lower the firm's financial flexibility.

P3 Health Corporate Bonds Issued

PIII Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how P3 Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PIII shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as P3 Health. By using and applying PIII Stock analysis, traders can create a robust methodology for identifying PIII entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PIII analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PIII analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

P3 Health Partners stock analysis indicators help investors evaluate how P3 Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading P3 Health shares will generate the highest return on investment. By understating and applying P3 Health stock analysis, traders can identify P3 Health position entry and exit signals to maximize returns.

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.